We were unable to process your request. Please try again later. If you continue to have this issue please contact [email protected]. Secukinumab 300 mg administered with an auto-injector ...
BURLINGTON, Mass., April 24, 2024 (GLOBE NEWSWIRE) -- scPharmaceuticals Inc. (Nasdaq: SCPH) (the “Company”), a pharmaceutical company focused on developing and commercializing products that have the ...
BD (Becton, Dickinson and Company), a leading global medical technology company, today announced the launch of the BD Intevia™ 1 mL two-step disposable autoinjector, a robust platform device combining ...
Epinephrine Injection in a 30 mg per 30 mL Multi-Dose Vial is now available from Fresenius Kabi, expanding the company’s offerings of Epinephrine Injection. In December 2024, Fresenius Kabi introduced ...
MINNETONKA, Minn.--(BUSINESS WIRE)--Milla Pharmaceuticals Inc., an A.forall company, announced that its partner, Woodward Pharma Services LLC, has just commercialized its Supplemental Abbreviated New ...
Infrapatellar fat pad (IPFP) glucocorticoid injections do not significantly reduce pain or effusion volume compared to ...
Fresenius Kabi announced today the U.S. introduction of Fentanyl Citrate Injection, USP 50 mcg per 1 mL in its proprietary Simplist (R) ready-to-administer prefilled syringe, the only 1 mL ...
Company anticipates topline data in Q3 2024, followed by a Supplemental New Drug Application (sNDA) by year-end 2024, if successful BURLINGTON, Mass., April 24, 2024 (GLOBE NEWSWIRE) -- ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback